Rocket Lab Corporation (RKLB)
Quantitative Summary
DeterministicFinancial health is average: Piotroski 5/9, Altman Z 38.9. Beneish M-Score of -2.19 exceeds the -2.22 academic threshold — earnings quality may warrant further review.
Generated deterministically from quant metrics and financial statements. Not a recommendation.
Algorithmic Teardown
AI-GeneratedThe fundamental economics of RKLB present a stark dichotomy between aggressive top-line expansion and deteriorating capital efficiency. While revenue growth remains robust at 38% year-over-year, the company is generating value destruction rather than accumulation; an ROIC of -7.9% combined with a negative net margin of -32.9% indicates that current operations are burning cash despite maintaining healthy gross margins near 34%. The DuPont decomposition reveals this drag stems primarily from profitability pressures outweighing asset turnover and leverage, resulting in a negative ROE of -11.5%. Although the Piotroski F-Score of 5/9 suggests moderate financial stability relative to distressed peers, the Beneish M-Score of -2.19 flags potential earnings manipulation risks that warrant skepticism regarding the quality of reported growth figures.
Valuation metrics reflect market pricing for high volatility rather than intrinsic value creation. The stock exhibits a significant growth tilt with a Value Factor (HML) of -0.448, while its Profitability Factor (RMW) of -2.798 underscores severe weakness in earnings power relative to industry standards. This disconnect is further highlighted by an annual Fama-French Alpha of 100.16%, suggesting the security has significantly outperformed traditional risk factors over the measurement period, likely driven by speculative momentum rather than fundamental improvements. Without a clear path to restoring positive net margins or improving ROIC, any current multiple expansion appears disconnected from sustainable cash flow generation capabilities.
Insider activity provides a critical counter-narrative to the revenue growth story. Over the past 90 days, insiders have executed $137.7 million in net selling, a substantial outflow that often signals management's lack of confidence in near-term equity valuation or future profitability trajectories when combined with negative operating margins. This capital flight contrasts sharply with the company's revenue acceleration, creating an asymmetry where top-line metrics improve while ownership structure weakens and fundamental returns remain deeply negative. Investors must weigh whether the 38% revenue surge can eventually bridge the gap between current losses and positive risk-adjusted returns before considering entry points based on speculative alpha alone.
Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.
Price Chart with Moving Averages
Quant Health Deep Dive
Profitability & Value Creation
DuPont Analysis — ROE Decomposition
Breaking down Return on Equity to see how the company generates its ROE — efficiency, margins, or leverage.
Balance Sheet Health
Insider Activity (Last 90 Days)
Open-market buys vs sells by company insiders. Source: yfinance.
Earnings Surprise History
EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.
Risk Profile
Sharpe = risk-adjusted return (higher is better). Max drawdown = largest peak-to-trough decline. 1,200+ trading days.
Underwater (Drawdown from Peak)
How far below the all-time high the price has been over time. Deeper = more pain for holders.
Rolling 60-Day Beta vs S&P 500 (VOO)
How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.
Fama-French 5-Factor Exposure
Academic factor model decomposition — what's really driving this stock's returns.
Fama-French 5-Factor Model. Data: Kenneth French Data Library. Regression over 3 years of daily returns.
Fundamentals
Passive Flow Attribution
ETF Draft EffectWhen investors buy or sell ETFs like XAR or ITA, the fund manager is mechanically forced to buy or sell RKLB shares regardless of Rocket Lab Corporation's individual fundamentals. We estimate $4.5B of passive capital is structurally linked to RKLB through 8 tracked ETFs. Index rebalances and ETF creation/redemption cycles can create noticeable volume spikes unrelated to company news.
Passive exposure = Σ (ETF AUM × stock weight in ETF) across 8 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.
ETF Contagion Visualizer
Simulate a price drop in Rocket Lab Corporation to visualize passive redemption contagion across ETFs and collateral stocks.
If Rocket Lab Corporation (RKLB) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies GE Aerospace (GE) as the most exposed collateral stock, sharing 1 ETFs with RKLB. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.
Contagion model based on shared ETF exposure and constituent weights across 18 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.
RKLB Ownership Dynamics
Passive funds hold 1 in every 12 RKLB shares, reducing daily market volatility.
Rocket Lab Corporation (RKLB) exerts measurable gravity on the passive index market, currently representing 5.5% of the XAR (XAR) and 3.3% of the ITA (ITA). Across 16 tracked ETFs, approximately 50M shares (8.7% of float) are held by passive funds and rarely trade on the open market. As passive ownership grows, index inclusion changes may increasingly drive price discovery.
ETFs with Highest RKLB Exposure
Float lock-up computed from 16 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).
RKLB Institutional Volume Profile
252-day volume distribution by price level. The Point of Control (POC) marks — the price where the most institutional volume transacted — an implicit support/resistance floor.
The highest-volume price zone for Rocket Lab Corporation over the past year sits near $47.25 (18% of 252-day volume). The current price of $123.32 trades 161.0% above this institutional floor — a sign of upside momentum, though a pullback to the POC zone is a common reversion target. The highly concentrated volume profile (18% at POC) indicates strong consensus on fair value — institutional participants have repeatedly transacted near this price.
Volume Profile computed from 252 trading days of OHLCV data. Volume allocated to price bins proportionally based on daily high-low range. Not investment advice.
Fails-to-Deliver (FTD) History
SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.
| Date | Failed Shares | Close Price | Notional Value |
|---|---|---|---|
| 2026-05-14 | 141 | $124.15 | $17,505.15 |
| 2026-05-11 | 12,282 | $105.47 | $1.3M |
| 2026-05-08 | 129,126 | $78.58 | $10.1M |
| 2026-05-05 | 1,846 | $80.31 | $148,252.26 |
| 2026-04-27 | 205 | $79.68 | $16,334.4 |
| 2026-04-22 | 6 | $86.64 | $519.84 |
| 2026-04-20 | 95,195 | $84.80 | $8.1M |
| 2026-04-17 | 49,997 | $82.93 | $4.1M |
| 2026-04-15 | 6,525 | $72.22 | $471,235.5 |
| 2026-04-13 | 700 | $68.05 | $47,635 |
| 2026-04-10 | 32,328 | $66.74 | $2.2M |
| 2026-04-09 | 6,716 | $69.08 | $463,941.28 |
| 2026-04-07 | 2,146 | $67.67 | $145,219.82 |
| 2026-04-06 | 194,387 | $67.73 | $13.2M |
| 2026-04-02 | 7,054 | $65.52 | $462,178.08 |
| 2026-04-01 | 16,180 | $64.22 | $1.0M |
| 2026-03-31 | 2 | $57.38 | $114.76 |
| 2026-03-30 | 378 | $60.93 | $23,031.54 |
| 2026-03-27 | 570,323 | $65.94 | $37.6M |
| 2026-03-26 | 1,462 | $72.88 | $106,550.56 |
| 2026-03-25 | 10,814 | $66.07 | $714,480.98 |
| 2026-03-24 | 1,405 | $68.00 | $95,540 |
| 2026-03-23 | 16,375 | $67.23 | $1.1M |
| 2026-03-17 | 10,954 | $71.31 | $781,129.74 |
| 2026-03-13 | 635 | $68.37 | $43,414.95 |
| 2026-03-10 | 646 | $71.48 | $46,176.08 |
| 2026-02-26 | 1,097 | $70.20 | $77,009.4 |
| 2026-02-24 | 200 | $70.21 | $14,042 |
| 2026-02-23 | 7,100 | $70.86 | $503,106 |
| 2026-02-18 | 22,483 | $69.89 | $1.6M |
Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.
Price Correlations
Statistical correlation of daily returns with other stocks. High correlations indicate stocks that move together; negative correlations can offer diversification.
| Peer | 252-Day (1Y) | 126-Day (6M) | Direction |
|---|---|---|---|
| WTGXX | NaN | NaN | |
| ASTS | 0.657 | 0.794 | Moderate |
| ACHR | 0.543 | 0.687 | Moderate |
| LEU | 0.485 | 0.638 | Moderate |
| KTOS | 0.482 | 0.644 | Moderate |
| PLTR | 0.472 | 0.567 | Moderate |
| HOOD | 0.456 | 0.558 | Moderate |
| SOFI | 0.449 | 0.493 | Moderate |
| SARO | 0.437 | 0.558 | Moderate |
| CW | 0.434 | 0.521 | Moderate |
Pearson correlation of daily log returns. 252d ≈ 1 trading year. Computed from price history. Not investment advice.
Compare RKLB to Peers
Quant metrics computed deterministically from financial statements and price data. Updated: 2026-06-02.
SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.